FDA Accepts Roflumilast Foam NDA for the Treatment of Seborrheic Dermatitis (dermatologytimes.com) 1 points by phreack 3y ago ↗ HN
0 comments
[ 3.6 ms ] story [ 16.6 ms ] threadNo comments yet.